Answers are grounded in this paper and cite their sources.
Analysis reveals behavioral and neuropsychiatric symptom severity in bvFTD and PPA, highlighting clinical implications.
Our findings demonstrate that behavioral and neuropsychiatric symptoms are prevalent in both bvFTD and PPA. Their severity depends on the disease duration, phenotypic group, and sex. This detailed understanding of symptomatology is crucial for optimizing patient care, diagnostic evaluations, and the design of clinical trials. Limitations comprise the lack of neuropathologic validation and the limited availability of MRI data.
No takes yet. Share an insight, caveat, or question.
Marth et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: